---
document_datetime: 2024-07-23 15:38:36
document_pages: 40
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/vaxelis-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: vaxelis-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 20.9591175
conversion_datetime: 2025-12-19 01:23:44.982471
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## Vaxelis

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                                             | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IA/0145              | B.II.e.1.b.3 - Change in immediate packaging of the finished product - Change in type/addition of a new container - Deletion of an immediate packaging container without a complete deletion of a strength or pharmaceutical form | 17/07/2024                          |                                             | SmPC, Labelling and PL           |           |

1 Notifications  are issued for  type I variations  and Article  61(3) notifications  (unless part of a group including a type II variation  or extension  application  or a worksharing  application).  Opinions are  issued for all  other procedures.

2 A Commission  decision  (CD) is issued for procedures  that affect  the terms of the marketing  authorisation  (e.g.  summary of  product characteristics,  annex  II, labelling,  package  leaflet).  The CD is issued within two  months of  the opinion  for variations  falling  under the scope of  Article  23.1a(a)  of Regulation  (EU) No.  712/2012, or within  one year  for other procedures.

3 SmPC  (Summary  of Product Characteristics),  Annex  II, Labelling,  PL (Package  Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| II/0141   | B.I.e.2 - Introduction of a post approval change management protocol related to the AS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 06/06/2024   | n/a   |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|
| IB/0143/G | This was an application for a group of variations. B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                                                                                                                                                                               | 08/05/2024   | n/a   |
| IB/0142   | B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 08/05/2024   | n/a   |
| IB/0139/G | This was an application for a group of variations. B.I.a.4.b - Change to in-process tests or limits applied during the manufacture of the AS - Addition of a new in-process test and limits B.I.a.4.b - Change to in-process tests or limits applied during the manufacture of the AS - Addition of a new in-process test and limits B.I.a.4.b - Change to in-process tests or limits applied during the manufacture of the AS - Addition of a new in-process test and limits B.I.a.4.b - Change to in-process tests or limits applied during the manufacture of the AS - Addition of a new in-process test and limits B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting | 15/04/2024   | n/a   |

<div style=\"page-break-after: always\"></div>

|           | material/intermediate/reagent - Tightening of specification limits B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method B.I.b.z - Change in control of the AS - Other variation B.III.2.b - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Change to comply with an update of the relevant monograph of the Ph. Eur. or national pharmacopoeia of a Member State                                                                                                                               |            |     |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| II/0136/G | This was an application for a group of variations. B.I.b.2.d - Change in test procedure for AS or starting material/reagent/intermediate - Substantial change to or replacement of a biological/immunological/immunochemical test method or a method using a biological reagent for a biological AS B.I.b.1.g - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Widening of the approved specs for starting mat./intermediates, which may have a significant effect on the quality of the AS and/or the FP B.I.b.2.d - Change in test procedure for AS or starting material/reagent/intermediate - Substantial change to or replacement of a | 11/01/2024 | n/a |

<div style=\"page-break-after: always\"></div>

|         | biological/immunological/immunochemical test method or a method using a biological reagent for a biological AS B.III.2.b - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Change to comply with an update of the relevant monograph of the Ph. Eur. or national pharmacopoeia of a Member State B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate   |            |     |             |                                                                                                                                                                                                   |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0138 | B.II.d.2.z - Change in test procedure for the finished product - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 04/01/2024 | n/a |             |                                                                                                                                                                                                   |
| II/0134 | Update of section 4.8 of the SmPC in order to add Extensive swelling of vaccinated limb to the list of adverse drug reactions (ADRs) with frequency rare and to update its description based on the cumulative review of clinical studies, literature and safety database. The Package Leaflet is updated accordingly. C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data                                                                                                            | 14/12/2023 |     | SmPC and PL | The Vaxelis SmPC section 4.8 has been updated to include Extensive swelling of vaccinated limb with frequency rare. For more information, please refer to the Summary of Product Characteristics. |
| II/0128 | Update of section 4.5 in order to add drug-drug interaction information with meningococcal B conjugate vaccine based on final results from study                                                                                                                                                                                                                                                                                                                                                                                                    | 07/12/2023 |     | SmPC and PL | The Vaxelis SmPC section 4.5 has been updated to include information on drug-drug interaction information with meningococcal B conjugate. Vaxelis may be administered at                          |

<div style=\"page-break-after: always\"></div>

|         | OVG 2018/05 - Immunogenicity and reactogenicity of concomitantly administered hexavalent and group B meningococcal vaccines in infancy; this is an open- label, non-inferiority, randomized clinical trial that compared the immune response and assessed the safety of Vaxelis and control vaccine (Infanrix hexa) when co-administered with 4 component meningococcal B vaccine (4CMenB) along with other routine infant vaccines. The Package Leaflet is updated accordingly. C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data   |            |     |      | the same time with meningococcal B vaccines. Due to an increase in some adverse reactions when a different hexavalent vaccine with a similar reactogenicity profile to Vaxelis was co-administered with Meningococcal B vaccine, separate vaccinations can be considered. For more information, please refer to the Summary of Product Characteristics.   |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0126 | Update of sections 4.2 and 5.1 of the SmPC in order to add information on interchangeable use of Vaxelis with other hexavalent vaccines based on final results from Study V419-016. In addition, the MAH took this opportunity to introduce minor editorial changes. C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data                                                                                                                                                                                                               | 30/11/2023 |     | SmPC | The Vaxelis SmPC sections 4.2 and 5.1 have been updated to include information on interchangeable use of Vaxelis with other hexavalent vaccines. Vaxelis may be used as a booster dose in children who received another hexavalent vaccine for their primary series. For more information, please refer to the Summary of Product Characteristics.        |
| II/0131 | B.II.d.2.c - Change in test procedure for the finished product - Substantial change to or replacement of a biol/immunol/immunochemical test method or a method using a biol. reagent or replacement of a biol. reference preparation not covered by an approved protocol                                                                                                                                                                                                                                                                                                                             | 23/11/2023 | n/a |      |                                                                                                                                                                                                                                                                                                                                                           |

<div style=\"page-break-after: always\"></div>

| II/0132             | B.II.d.2.c - Change in test procedure for the finished product - Substantial change to or replacement of a biol/immunol/immunochemical test method or a method using a biol. reagent or replacement of a biol. reference preparation not covered by an approved protocol                                                                                                                                                                                                      | 09/11/2023   | n/a   |                                   |
|---------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|-----------------------------------|
| IB/0133/G           | This was an application for a group of variations. B.I.b.2.b - Change in test procedure for AS or starting material/reagent/intermediate - Deletion of a test procedure for the AS or a starting material/reagent/intermediate, if an alternative test procedure is already authorised B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting | 25/10/2023   | n/a   |                                   |
| IB/0135             | B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition)                                                                                                                                                                                                                                                                                                                                        | 24/10/2023   | n/a   |                                   |
| PSUSA/10469 /202302 | Periodic Safety Update EU Single assessment - diphtheria / tetanus / pertussis (acellular, component) / hepatitis B (rDNA) / poliomyelitis (inactivated) / haemophilus type b conjugate vaccine (adsorbed)                                                                                                                                                                                                                                                                    | 28/09/2023   | n/a   | PRAC Recommendation - maintenance |

<div style=\"page-break-after: always\"></div>

| IB/0129   | - Change to in-process tests or limits during the manufacture of the AS - Other                                                                                                                              | 26/07/2023   | n/a   | B.I.a.4.z applied variation   |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|-------------------------------|
| IB/0130   | B.II.d.1.a - Change in the specification parameters and/or limits of the finished product - Tightening of specification limits                                                                               | 25/07/2023   | n/a   |                               |
| IB/0125/G | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites B.II.d.1.z - Change in the specification parameters finished product - Other variation      | 04/07/2023   | n/a   | and/or limits of the          |
| IA/0127   | B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits                                                       | 30/06/2023   | n/a   |                               |
| IB/0123   | B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                                                                             | 19/06/2023   | n/a   |                               |
| IB/0124   | B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate | 16/06/2023   | n/a   |                               |
| IB/0121   | B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other                                                                                                                | 16/06/2023   | n/a   |                               |

<div style=\"page-break-after: always\"></div>

|           | to a test procedure (including replacement addition) for the AS or a starting                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |            |     | changes or material/intermediate   |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|------------------------------------|
| II/0119/G | This was an application for a group of variations. B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation B.I.a.2.c - Changes in the manufacturing process of the AS - The change refers to a [-] substance in the manufacture of a biological/immunological substance which may have a significant impact on the medicinal product and is not related to a protocol B.I.a.4.c - Change to in-process tests or limits applied during the manufacture of the AS - Deletion | 08/06/2023 | n/a | of a non-significant in-process    |
| IA/0120   | B.I.b.2.b - Change in test procedure for AS or starting material/reagent/intermediate - Deletion of a test procedure for the AS or a starting material/reagent/intermediate, if an alternative test procedure is already authorised                                                                                                                                                                                                                                                                                                                    | 13/04/2023 | n/a |                                    |
| IB/0118/G | This was an application for a group of variations. B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate in test procedure for AS or                                                                                                                                                                                                                                                            | 24/03/2023 | n/a | B.I.b.2.e - Change                 |

<div style=\"page-break-after: always\"></div>

|         | starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate                                                                                              |            |     |             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0115 | B.I.a.2.c - Changes in the manufacturing process of the AS - The change refers to a [-] substance in the manufacture of a biological/immunological substance which may have a significant impact on the medicinal product and is not related to a protocol | 23/03/2023 | n/a |             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| IB/0117 | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                                                       | 14/02/2023 | n/a |             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| IB/0116 | B.I.b.2.z - Change in test procedure for AS or starting material/reagent/intermediate - Other variation                                                                                                                                                    | 13/02/2023 | n/a |             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| II/0110 | C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data                                                                                                                                          | 26/01/2023 |     | SmPC and PL | 'Hypersensitivity' and 'Anaphylactic reaction' were added to the table of adverse events reported during post- marketing use in Section 4.8 of the SmPC, with 'rare' as frequency. Accordingly, 'allergic reaction, serious allergic reaction (anaphylactic reaction)' was added to the list of side effects in section 4 of the PL with frequency 'rare'. Consequently, the paragraph on hypersensitivity and anaphylactic reaction - previously part of the description of selected adverse reactions reported with other vaccines containing the components or constituents of Vaxelis without regard to causality or frequency - was deleted from the SmPC (section 4.8) and the PL (section 4) approved with this variation. |

<div style=\"page-break-after: always\"></div>

|         |                                                                                                                                                                                                                                                                                   |            |     |      | For more information, please refer to the Summary of Product Characteristics.   |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|------|---------------------------------------------------------------------------------|
| WS/2361 | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure | 19/01/2023 | n/a |      |                                                                                 |
| IB/0113 | B.II.f.1.d - Stability of FP - Change in storage conditions of the finished product or the diluted/reconstituted product                                                                                                                                                          | 16/12/2022 |     | SmPC |                                                                                 |
| IA/0114 | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                                                                      | 13/12/2022 | n/a |      |                                                                                 |
| II/0109 | B.I.a.2.c - Changes in the manufacturing process of the AS - The change refers to a [-] substance in the manufacture of a biological/immunological substance which may have a significant impact on the medicinal product and is not related to a protocol                        | 01/12/2022 | n/a |      |                                                                                 |
| WS/2360 | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. B.I.b.2.e - Change in test procedure for AS or                                                                                      | 01/12/2022 | n/a |      |                                                                                 |

<div style=\"page-break-after: always\"></div>

|           | changes to a test procedure (including replacement addition) for the AS or a starting material/intermediate                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |            |     | or                |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-------------------|
| II/0107   | B.II.d.2.c - Change in test procedure for the finished product - Substantial change to or replacement of a biol/immunol/immunochemical test method or a method using a biol. reagent or replacement of a biol. reference preparation not covered by an                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 17/11/2022 | n/a | approved protocol |
| IB/0111/G | This was an application for a group of variations. B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS | 07/11/2022 | n/a |                   |

<div style=\"page-break-after: always\"></div>

| II/0104/G   | This was an application for a group of variations.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 08/09/2022   | 09/12/2022   | SmPC and PL   |
|-------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|---------------|
| IB/0105/G   | This was an application for a group of variations. B.I.b.2.b - Change in test procedure for AS or starting material/reagent/intermediate - Deletion of a test procedure for the AS or a starting material/reagent/intermediate, if an alternative test procedure is already authorised B.I.b.2.z - Change in test procedure for AS or starting material/reagent/intermediate - Other variation B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate B.I.b.1.d - Change in the specification parameters | 18/08/2022   | n/a          |               |

<div style=\"page-break-after: always\"></div>

|           | material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter) B.I.b.2.b - Change in test procedure for AS or starting material/reagent/intermediate - Deletion of a test procedure for the AS or a starting material/reagent/intermediate, if an alternative test procedure is already authorised B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter) B.I.a.4.b - Change to in-process tests or limits applied during the manufacture of the AS - Addition of a new in-process test and limits   |            |            |          |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------|
| IA/0106   | A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 10/08/2022 | 09/12/2022 | Annex II |
| II/0097   | B.II.d.1.e - Change in the specification parameters and/or limits of the finished product - Change outside the approved specifications limits range                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 21/07/2022 | n/a        |          |
| IB/0102/G | This was an application for a group of variations. B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 25/05/2022 | n/a        |          |

<div style=\"page-break-after: always\"></div>

|         | in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter)   |            |            |    | B.I.b.1.z - Change   |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----|----------------------|
| IB/0101 | B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate                                                                                                                           | 17/05/2022 | n/a        |    |                      |
| IB/0100 | B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                                                                                                                                                                                                       | 17/05/2022 | n/a        |    |                      |
| IB/0098 | B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                                                                                                                                                                                                       | 13/04/2022 | n/a        |    |                      |
| N/0099  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                       | 04/04/2022 | 09/12/2022 | PL |                      |
| II/0095 | B.I.b.2.d - Change in test procedure for AS or starting material/reagent/intermediate - Substantial change to or replacement of a biological/immunological/immunochemical test method or a method using a biological reagent for a biological AS                                                                                       | 17/03/2022 | n/a        |    |                      |

<div style=\"page-break-after: always\"></div>

| II/0093/G   | This was an application for a group of variations. B.I.c.1.b - Change in immediate packaging of the AS - Qualitative and/or quantitative composition for sterile and non-frozen biological/immunological ASs B.I.b.z - Change in control of the AS - Other variation B.I.b.z - Change in control of the AS - Other variation B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place B.I.a.2.c - Changes in the manufacturing process of the AS - The change refers to a [-] substance in the manufacture of a biological/immunological substance   | 10/02/2022   | n/a   |
|-------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|
| IA/0096/G   | This was an application for a group of variations.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 07/02/2022   | n/a   |

<div style=\"page-break-after: always\"></div>

|           | in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor approved test procedure   |            |            |                        | B.I.b.2.a - Change changes to an   |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|------------------------------------|
| II/0088   | C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data                                                                                                                                                                                                                                                                                                                                                                                                | 27/01/2022 | 09/12/2022 | SmPC, Labelling and PL |                                    |
| WS/2173   | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. B.I.d.1.z - Stability of AS - Change in the re-test period/storage period or storage conditions - Other variation                                                                                                                                                                                                                                                  | 13/01/2022 | n/a        |                        |                                    |
| IB/0094/G | This was an application for a group of variations. B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.1.z - Change in the specification parameters limits of an AS, starting                                                                                                                                                                                                                                              | 22/12/2021 | n/a        |                        | and/or                             |

<div style=\"page-break-after: always\"></div>

|           | material/intermediate/reagent - Other variation - Change in the specification parameters limits of an AS, starting material/intermediate/reagent - Other variation                                                                                                                                                                                                                                                                                     |            |            |             | B.I.b.1.z and/or       |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|------------------------|
| IB/0092/G | This was an application for a group of variations. B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting | 13/12/2021 | n/a        |             | material/intermediate  |
| II/0090   | C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data                                                                                                                                                                                                                                                                                                                                      | 02/12/2021 | 09/12/2022 | SmPC and PL |                        |
| WS/2143   | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. B.I.a.2.z - Changes in the manufacturing process of the AS - Other variation                                                                                                                                                                                                                             | 11/11/2021 | n/a        |             |                        |
| II/0085/G | This was an application for a group of variations. the manufacturing process of                                                                                                                                                                                                                                                                                                                                                                        | 16/09/2021 | n/a        |             | B.I.a.2.c - Changes in |

<div style=\"page-break-after: always\"></div>

|         | the AS - The change refers to a [-] substance in the manufacture of a biological/immunological substance which may have a significant impact on the medicinal product and is not related to a protocol B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter) B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation B.I.b.1.a - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits for medicinal products subject to   |            |     |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| IB/0087 | B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 26/08/2021 | n/a |
| IA/0086 | B.III.1.b.3 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - Updated certificate from an already approved manufacturer                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 02/08/2021 | n/a |

<div style=\"page-break-after: always\"></div>

| IB/0084   | B.II.d.1.z - Change in the specification parameters and/or limits of the finished product - Other variation                                                                                                                                                                                                                                                                        | 13/07/2021   | n/a   |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|
| II/0079   | B.I.a.2.c - Changes in the manufacturing process of the AS - The change refers to a [-] substance in the manufacture of a biological/immunological substance which may have a significant impact on the medicinal product and is not related to a protocol                                                                                                                         | 17/06/2021   | n/a   |
| IB/0082   | B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation                                                                                                                                                                                                                                                                        | 14/06/2021   | n/a   |
| IA/0083   | B.III.1.b.2 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - New certificate for a starting material/reagent/intermediate/or excipient from a new or an already approved manufacturer                                                                                                                                                        | 03/06/2021   | n/a   |
| II/0077   | B.I.b.2.z - Change in test procedure for AS or starting material/reagent/intermediate - Other variation                                                                                                                                                                                                                                                                            | 28/05/2021   | n/a   |
| II/0076/G | This was an application for a group of variations. B.II.d.2.c - Change in test procedure for the finished product - Substantial change to or replacement of a biol/immunol/immunochemical test method or a method using a biol. reagent or replacement of a biol. reference preparation not covered by an approved protocol B.II.d.2.c - Change in test procedure for the finished | 20/05/2021   | n/a   |

<div style=\"page-break-after: always\"></div>

|           | product - Substantial change to or replacement of a biol/immunol/immunochemical test method or a method using a biol. reagent or replacement of a biol. reference preparation not covered by an approved protocol                                                                                                                                                                                                                                                               |            |     |    |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|----|
| IA/0081/G | This was an application for a group of variations. B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure                                                                                                                                                                              | 06/05/2021 | n/a |    |
| IB/0080   | B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate                                                                                                                                                                                                                                                                    | 06/05/2021 | n/a |    |
| IB/0078/G | This was an application for a group of variations. B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter) B.III.2.a.2 - Change of specification(s) of a former non EU Pharmacopoeial substance to fully comply with the Ph. Eur. or with a national pharmacopoeia of Member State - Excipient/AS starting material | 05/05/2021 | n/a | a  |

<div style=\"page-break-after: always\"></div>

B.III.2.a.2  - Change  of specification(s)  of a former non EU Pharmacopoeial substance to fully  comply with the Ph. Eur. or with a national  pharmacopoeia  of a Member State  - Excipient/AS  starting material B.III.2.a.2  - Change  of specification(s)  of a former non EU Pharmacopoeial substance to fully  comply with the Ph. Eur. or with a national  pharmacopoeia  of a Member State  - Excipient/AS  starting material B.III.2.a.2  - Change  of specification(s)  of a former non EU Pharmacopoeial substance to fully  comply with the Ph. Eur. or with a national  pharmacopoeia  of a Member State  - Excipient/AS  starting material B.III.2.a.2  - Change  of specification(s)  of a former non EU Pharmacopoeial substance to fully  comply with the Ph. Eur. or with a national  pharmacopoeia  of a Member State  - Excipient/AS  starting material B.III.2.a.2  - Change  of specification(s)  of a former non EU Pharmacopoeial substance to fully  comply with the Ph. Eur. or with a national  pharmacopoeia  of a Member State  - Excipient/AS  starting material B.III.2.a.2  - Change  of specification(s)  of a former non EU Pharmacopoeial substance to fully  comply with the Ph. Eur. or with a national  pharmacopoeia  of a Member State  - Excipient/AS  starting material B.I.b.1.d  - Change in the specification  parameters and/or  limits of  an AS,  starting material/intermediate/reagent - Deletion  of  a nonsignificant  specification  parameter  (e.g.  deletion  of an obsolete  parameter) B.I.b.1.d  - Change in the specification  parameters and/or  limits of  an AS,  starting material/intermediate/reagent - Deletion  of  a non-

<div style=\"page-break-after: always\"></div>

|         | significant specification parameter (e.g. deletion of an obsolete parameter) B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation                                                         |            |     |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| II/0075 | B.II.d.2.c - Change in test procedure for the finished product - Substantial change to or replacement of a biol/immunol/immunochemical test method or a method using a biol. reagent or replacement of a biol. reference preparation not covered by an approved protocol | 15/04/2021 | n/a |
| II/0073 | B.I.a.2.c - Changes in the manufacturing process of the AS - The change refers to a [-] substance in the manufacture of a biological/immunological substance which may have a significant impact on the medicinal product and is not related to a protocol               | 18/03/2021 | n/a |
| II/0074 | B.I.a.2.c - Changes in the manufacturing process of the AS - The change refers to a [-] substance in the manufacture of a biological/immunological substance which may have a significant impact on the medicinal product and is not related to a protocol               | 11/03/2021 | n/a |
| II/0070 | B.II.d.1.f - Change in the specification parameters and/or limits of the finished product - Deletion of a specification parameter which may have a significant effect on the overall quality of the finished product                                                     | 04/02/2021 | n/a |
| IB/0072 | B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting                                                                                                                                                                                      | 18/12/2020 | n/a |

<div style=\"page-break-after: always\"></div>

|                     | material/intermediate/reagent - Other variation                                                                                                                                                                                                                              |            |     |                                   |
|---------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------------------------|
| IB/0071/G           | This was an application for a group of variations. B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure | 16/12/2020 | n/a |                                   |
| IB/0068             | B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate                                                                 | 10/11/2020 | n/a |                                   |
| IB/0069             | B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition)                                                                                                                                       | 06/11/2020 | n/a |                                   |
| IB/0067/G           | This was an application for a group of variations. B.I.z - Quality change - Active substance - Other variation B.I.z - Quality change - Active substance - Other variation                                                                                                   | 22/10/2020 | n/a |                                   |
| PSUSA/10469 /202002 | Periodic Safety Update EU Single assessment - diphtheria / tetanus / pertussis (acellular, component) / hepatitis B (rDNA) / poliomyelitis (inactivated) / haemophilus type b conjugate vaccine                                                                              | 01/10/2020 | n/a | PRAC Recommendation - maintenance |

<div style=\"page-break-after: always\"></div>

|           | (adsorbed)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |            |            |                        |                                                                                                                                                                                                                                                                       |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| R/0065    | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 23/07/2020 | 24/09/2020 | SmPC, Labelling and PL | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Vaxelis in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity. |
| WS/1804/G | This was an application for a group of variations following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.2.c - Changes in the manufacturing process of the AS - The change refers to a [-] substance in the manufacture of a biological/immunological substance which may have a significant impact on the medicinal product and is not related to a protocol | 30/04/2020 | n/a        |                        |                                                                                                                                                                                                                                                                       |
| IB/0064/G | This was an application for a group of variations. B.I.a.4.b - Change to in-process tests or limits applied during the manufacture of the AS - Addition of a new in-process test and limits B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting                                                                                                                                                                                                                                                                                                                                                                      | 29/04/2020 | n/a        |                        |                                                                                                                                                                                                                                                                       |

<div style=\"page-break-after: always\"></div>

|           | material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter) B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.III.1.b.3 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - Updated certificate from an already approved manufacturer B.III.1.b.3 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - Updated certificate from an already approved manufacturer B.III.1.b.3 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - Updated certificate from an already approved manufacturer B.III.1.b.4 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - Deletion of certificates (in case multiple certificates exist per material) B.III.1.b.4 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - of certificates (in case multiple certificates   |            |     | Deletion   |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|------------|
| IB/0057/G | This was an application for a group of variations. B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 08/04/2020 | n/a |            |

<div style=\"page-break-after: always\"></div>

|           | Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - Updated certificate from an already approved manufacturer B.III.1.b.3 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - Updated certificate from an already approved manufacturer   |            |     | B.III.1.b.3 -   |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------|
| IB/0062   | B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition)                                                                                                                                                                        | 06/04/2020 | n/a |                 |
| IB/0061   | B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                                                                                                                                                                              | 06/04/2020 | n/a |                 |
| II/0055   | B.I.a.2.c - Changes in the manufacturing process of the AS - The change refers to a [-] substance in the manufacture of a biological/immunological substance which may have a significant impact on the medicinal product and is not related to a protocol                                                    | 02/04/2020 | n/a |                 |
| IA/0063/G | This was an application for a group of variations. B.II.d.1.a - Change in the specification parameters and/or limits of the finished product - Tightening of specification limits B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                | 27/03/2020 | n/a |                 |

<div style=\"page-break-after: always\"></div>

| IA/0060   | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                                                                                                                                                       | 27/03/2020   | n/a        |                        |                                                                                                                                                                                                                                                                                                                                    |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0059   | B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition)                                                                                                                                                                                                                                                                                                                                                                             | 24/03/2020   | n/a        |                        |                                                                                                                                                                                                                                                                                                                                    |
| IB/0056   | B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition)                                                                                                                                                                                                                                                                                                                                                                             | 28/02/2020   | n/a        |                        |                                                                                                                                                                                                                                                                                                                                    |
| II/0054   | Update of section 4.8 of the Vaxelis SmPC in order to add Hypotonic Hyporesponsive Episode to the list of post-marketing adverse events, based on a cumulative assessment of post-marketing data from the Marketing authorisation holder (MAH) global safety database. The Package Leaflet is updated accordingly. In addition, the MAH made minor editorial changes to the product information. C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data | 13/02/2020   | 24/09/2020 | SmPC and PL            | Hypotonic Hyporesponsive Episode is added as an adverse reaction with unknown frequency. Because these events of were reported from a population of uncertain size, it is generally not possible to reliably estimate their frequency or to establish, a causal relationship to the vaccine. The PL have been updated accordingly. |
| II/0052/G | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.e.1.b.2 - Change in immediate packaging of the finished product - Change in type/addition of a new                                                                                                                                                                                                                                                      | 23/01/2020   | 24/09/2020 | SmPC, Labelling and PL |                                                                                                                                                                                                                                                                                                                                    |

<div style=\"page-break-after: always\"></div>

|                     | biological/immunological medicinal products B.II.e.1.z - Change in immediate packaging of the finished product - Other variation C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing   |            |     |                                   |
|---------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------------------------|
| IB/0053             | B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                                                                                      | 09/12/2019 | n/a |                                   |
| IB/0051             | B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation                                                                                                                                                                                                                                                                                                                                      | 10/10/2019 | n/a |                                   |
| PSUSA/10469 /201902 | Periodic Safety Update EU Single assessment - diphtheria / tetanus / pertussis (acellular, component) / hepatitis B (rDNA) / poliomyelitis (inactivated) / haemophilus type b conjugate vaccine (adsorbed)                                                                                                                                                                                                                                                               | 05/09/2019 | n/a | PRAC Recommendation - maintenance |
| IA/0050/G           | This was an application for a group of variations. B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits                                                                                                                                                                                                                                                                | 26/07/2019 | n/a |                                   |

<div style=\"page-break-after: always\"></div>

|                     | B.III.1.b.4 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - Deletion of certificates (in case multiple certificates exist per material)                                        |            |            |             |                                   |
|---------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|-----------------------------------|
| IB/0049             | B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate          | 05/06/2019 | n/a        |             |                                   |
| IA/0047             | B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure                                                                                   | 03/04/2019 | n/a        |             |                                   |
| PSUSA/10469 /201808 | Periodic Safety Update EU Single assessment - diphtheria / tetanus / pertussis (acellular, component) / hepatitis B (rDNA) / poliomyelitis (inactivated) / haemophilus type b conjugate vaccine (adsorbed)            | 14/03/2019 | n/a        |             | PRAC Recommendation - maintenance |
| IA/0046             | B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method | 23/01/2019 | n/a        |             |                                   |
| IB/0045             | B.II.f.1.d - Stability of FP - Change in storage conditions of the finished product or the diluted/reconstituted product                                                                                              | 14/01/2019 | 13/01/2020 | SmPC and PL |                                   |

<div style=\"page-break-after: always\"></div>

| IAIN/0044/G   | This was an application for a group of variations. A.7 - Administrative change - Deletion of                                                                                                                                                                    | 12/12/2018   | n/a   |
|---------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|
| IA/0043       | B.I.b.2.b - Change in test procedure for AS or starting material/reagent/intermediate - Deletion of a test procedure for the AS or a starting material/reagent/intermediate, if an alternative test procedure is already authorised                             | 12/12/2018   | n/a   |
| II/0040       | B.I.b.2.d - Change in test procedure for AS or starting material/reagent/intermediate - Substantial change to or replacement of a biological/immunological/immunochemical test method or a method using a biological reagent for a biological AS                | 08/11/2018   | n/a   |
| IB/0041       | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                                                    | 10/10/2018   | n/a   |
| IB/0039/G     | This was an application for a group of variations. B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate | 06/09/2018   | n/a   |

<div style=\"page-break-after: always\"></div>

|                     | B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data                                                                                                                                                                                                           |            |     |                                   |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------------------------|
| PSUSA/10469 /201802 | Periodic Safety Update EU Single assessment - diphtheria / tetanus / pertussis (acellular, component) / hepatitis B (rDNA) / poliomyelitis (inactivated) / haemophilus type b conjugate vaccine (adsorbed)                                                                                                                                                                       | 06/09/2018 | n/a | PRAC Recommendation - maintenance |
| IB/0038             | B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                                                                                                                                                                                                                                                 | 05/09/2018 | n/a |                                   |
| IB/0037             | B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition)                                                                                                                                                                                                                                           | 26/06/2018 | n/a |                                   |
| IB/0036/G           | This was an application for a group of variations. B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data | 26/06/2018 | n/a |                                   |
| II/0030             | B.I.z - Quality change - Active substance - Other variation                                                                                                                                                                                                                                                                                                                      | 31/05/2018 | n/a |                                   |

<div style=\"page-break-after: always\"></div>

| IB/0034   | B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate                                                                                                                                                                                        | 16/05/2018   | n/a   |                       |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|-----------------------|
| IB/0033   | B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting                                                                                                                                                                                                              | 16/05/2018   | n/a   | material/intermediate |
| IB/0032/G | This was an application for a group of variations. B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate | 16/05/2018   | n/a   |                       |
| IA/0031/G | This was an application for a group of variations. B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter) Change in the specification parameters                                                                                       | 02/05/2018   | n/a   | B.I.b.1.d -           |

<div style=\"page-break-after: always\"></div>

|                     | and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter)                                                                                                                                                                                                                                                  |            |            |    |                                   |
|---------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----|-----------------------------------|
| N/0029              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                  | 06/04/2018 | 13/01/2020 | PL |                                   |
| II/0026             | B.II.d.2.c - Change in test procedure for the finished product - Substantial change to or replacement of a biol/immunol/immunochemical test method or a method using a biol. reagent or replacement of a biol. reference preparation not covered by an approved protocol                                                                                                                                          | 15/03/2018 | n/a        |    |                                   |
| PSUSA/10469 /201708 | Periodic Safety Update EU Single assessment - diphtheria / tetanus / pertussis (acellular, component) / hepatitis B (rDNA) / poliomyelitis (inactivated) / haemophilus type b conjugate vaccine (adsorbed)                                                                                                                                                                                                        | 08/03/2018 | n/a        |    | PRAC Recommendation - maintenance |
| IB/0028/G           | This was an application for a group of variations. B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation | 26/02/2018 | n/a        |    |                                   |

<div style=\"page-break-after: always\"></div>

|           | B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation                                                                                                                                                                                                                                                                                                                                                                                          |            |            |                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|--------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0025/G | This was an application for a group of variations. B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other | 22/01/2018 | n/a        |                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| IB/0023   | B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition)                                                                                                                                                                                                                                                                                                                                                                                       | 11/01/2018 | n/a        |                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| II/0021   | Update of section 5.1 of the SmPC in order to update the efficacy section on immune persistence based on the final results from study PRI03C - Long-term Persistence of Hepatitis B and Pertussis Antibody Responses in Healthy 4- to 5-year-old Children Previously Vaccinated with a 2 dose or 3 dose Infants Series and Toddler dose of Vaxelis or INFANRIX hexa listed as P46 study in the PIP. The RMP version 2.2 has also been submitted.                                                                             | 11/01/2018 | 15/03/2018 | SmPC and Labelling | The SmPC section 5.1 has been updated following the completion of PRI03C study with the data on long- term immune persistence following the vaccination with Vaxelis. The purpose of this study was to provide the results of the long-term persistence of anti-Hepatitis B surface antigen (antiHBsAg) and pertussis antibody (PT, FHA, PRN and FIM) responses in children previously vaccinated with Vaxelis or Infanrix hexa. The data was collected 3 to 4 years after completion of a 2+1 or 3+1 vaccination schedule. |

<div style=\"page-break-after: always\"></div>

|                     | In addition, the MAH took the opportunity to introduce editorial changes in Annex IIIA. C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data   |            |     | The proportion of children seroprotected (anti-HBsAg 10 mIU/mL - accepted correlate of protection) after those vaccination schedules decreased by approximately 30% in approximately 4 years. Considerable study data suggest that individuals who have ever had a seroprotective response to HB vaccination will have a memory response that is protective against clinical disease if exposed to the HB virus. The immunogenicity findings also support the long-term persistence of pertussis antibody responses. After approximately 4 years, the percentages of children with anti-pertussis antibodies above Lower Limit of Quantification (LLOQ) were as follows: anti-PT 58.4%, anti- FHA 80.9%, anti-PRN 66.1% and anti-FIM 94.3%. Clinical data had confirmed that Vaxelis is comparable to currently licensed vaccine controls with respect to immunogenicity and safety, when given concomitantly with other licensed routine paediatric vaccines.   |
|---------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0027             | B.II.d.2.z - Change in test procedure for the finished product - Other variation                                                                                                                            | 20/12/2017 | n/a |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| IB/0024             | B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation                                                                         | 06/12/2017 | n/a |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| PSUSA/10469 /201702 | Periodic Safety Update EU Single assessment - diphtheria / tetanus / pertussis (acellular, component) / hepatitis B (rDNA) / poliomyelitis (inactivated) / haemophilus type b conjugate vaccine (adsorbed)  | 28/09/2017 | n/a | PRAC Recommendation - maintenance                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |

<div style=\"page-break-after: always\"></div>

| IA/0020   | B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method                                                        | 22/09/2017   | n/a   |           |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|-----------|
| IB/0019   | B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition)                                                                                                                                       | 15/08/2017   | n/a   |           |
|           | This was an application for a group of variations. B.I.b.2.z - Change in test procedure for AS or starting material/reagent/intermediate - Other variation B.I.d.1.z - Stability of AS - Change in the re-test period/storage period or storage conditions - Other variation | 10/08/2017   | n/a   | IB/0017/G |
| IB/0018   | B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate                                                                 | 09/08/2017   | n/a   |           |
| IB/0015   | B.II.c.2.d - Change in test procedure for an excipient - Other changes to a test procedure (including replacement or addition)                                                                                                                                               | 21/07/2017   | n/a   |           |
| II/0012/G | This was an application for a group of variations. B.I.a.2.c - Changes in the manufacturing process of                                                                                                                                                                       | 20/07/2017   | n/a   |           |

<div style=\"page-break-after: always\"></div>

the AS - The change refers  to a [-] substance in the manufacture  of a biological/immunological substance which may  have  a significant  impact on the medicinal product and is not related  to a protocol B.I.a.2.c  - Changes  in the manufacturing  process of the AS - The change refers  to a [-] substance in the manufacture  of a biological/immunological substance which may  have  a significant  impact on the medicinal product and is not related  to a protocol B.I.b.1.z  - Change in the specification  parameters and/or  limits of  an AS,  starting material/intermediate/reagent - Other variation B.I.b.1.z  - Change in the specification  parameters and/or  limits of  an AS,  starting material/intermediate/reagent - Other variation B.I.b.2.a  - Change  in test procedure  for AS or starting material/reagent/intermediate - Minor changes to an approved  test procedure B.I.b.2.d  - Change in test procedure  for AS or starting material/reagent/intermediate - Substantial change to or replacement  of  a biological/immunological/immunochemical  test method or a method using a biological  reagent for  a biological  AS B.I.b.2.e  - Change  in test procedure  for AS or starting material/reagent/intermediate - Other changes to a test procedure (including  replacement or addition)  for  the AS or a starting material/intermediate B.I.d.1.z  - Stability  of  AS - Change  in the re-test period/storage  period  or storage  conditions  - Other variation

<div style=\"page-break-after: always\"></div>

|           | - Change of specification(s) of a former EU Pharmacopoeial substance to fully comply the Ph. Eur. or with a national pharmacopoeia of Member State - Excipient/AS starting material                                                                                                                                                                                                                                                                                                                                                |            |            |                  | B.III.2.a.2 non with a    |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------|---------------------------|
| N/0016    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                   | 04/07/2017 | 15/03/2018 | Labelling and PL |                           |
| IB/0013/G | This was an application for a group of variations. B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation B.III.1.z - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - Other variation B.III.1.z - Submission of a new/updated or deletion Certificate of Suitability - Other | 09/06/2017 | n/a        |                  | of Ph. Eur. TSE variation |
| IB/0011   | B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition)                                                                                                                                                                                                                                                                                                                                                                                             | 08/06/2017 | n/a        |                  |                           |
| IB/0010   | B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate                                                                                                                                                                                                                                                                                                                       | 26/04/2017 | n/a        |                  |                           |

<div style=\"page-break-after: always\"></div>

| IB/0009             | B.I.z - Quality change - Active substance - Other variation                                                                                                                                                                                                            | 06/04/2017   | n/a        |                        |                                   |
|---------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|-----------------------------------|
| IAIN/0008           | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing                                 | 16/03/2017   | 15/03/2018 | Annex II and PL        |                                   |
| PSUSA/10469 /201608 | Periodic Safety Update EU Single assessment - diphtheria / tetanus / pertussis (acellular, component) / hepatitis B (rDNA) / poliomyelitis (inactivated) / haemophilus type b conjugate vaccine (adsorbed)                                                             | 09/03/2017   | n/a        |                        | PRAC Recommendation - maintenance |
| T/0007              | Transfer of Marketing Authorisation from Sanofi Pasteur MSD SNC to MCM Vaccine B.V. Transfer of Marketing Authorisation                                                                                                                                                | 19/12/2016   | 27/01/2017 | SmPC, Labelling and PL |                                   |
| IB/0005             | B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition)                                                                                                                                 | 24/10/2016   | n/a        |                        |                                   |
| IA/0004/G           | This was an application for a group of variations. B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter) | 19/10/2016   | n/a        |                        |                                   |

<div style=\"page-break-after: always\"></div>

|             | B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter)                                                                                                                                                                          |            |            |                 |
|-------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------|
| IA/0003     | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                                                                                                                                                                                         | 19/10/2016 | n/a        |                 |
| II/0002     | B.I.a.1.e - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - The change relates to a biological AS or a starting material [-] used in the manufacture of a biological/immunological product                                                                                                                                                          | 15/09/2016 | n/a        |                 |
| IAIN/0001/G | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing | 25/05/2016 | 27/01/2017 | Annex II and PL |